Boisjoly H, Gresset J, Fontaine N, Charest M, Brunette I, LeFrançois M, Deschênes J, Bazin R, Laughrea P A, Dubé I
Maisonneuve-Rosemont Hospital, University of Montreal, Canada.
Am J Ophthalmol. 1999 Jul;128(1):38-44. doi: 10.1016/s0002-9394(99)00071-9.
To validate the Visual Function-14 (VF-14) index of functional visual impairment in candidates for a corneal graft.
One hundred thirty-four patients who were candidates for a corneal graft participated in this study between August 1996 and February 1997. Demographic, ocular history, best-corrected visual acuity, and detailed ocular examination data were collected. Functional visual impairment information was obtained by telephone interviews using the following: VF-14, SF-36 (Short Form-36, a more generic measure of general health function), and Visual Symptom Score, and four questions measuring the overall amount of trouble with vision, dissatisfaction with vision, ocular pain, and discomfort.
The average age of corneal graft candidates was 64 +/- 18 years (range, 18 to 90 years) and 60% were women. The most frequent corneal disease was pseudophakic bullous keratopathy (41%). Ocular comorbidities included glaucoma or ocular hypertension (30%) and cataract (19%). The mean best-corrected visual acuity of the eye scheduled for surgery was 1.33 +/- 0.56 logMAR whereas the best eye best-corrected visual acuity was 0.36 +/- 0.44 logMAR. The mean VF-14 score was 73% +/- 26%, and the internal consistency was high, with a Cronbach alpha value of 0.94. The VF-14 correlated strongly with the best eye best-corrected visual acuity. It also correlated strongly with the Visual Symptom Score, the global measures of trouble and dissatisfaction with vision. Candidates for a corneal graft had low scores for all eight general health concepts evaluated with the SF-36, and the VF-14 correlated with seven of the eight SF-36 subscales.
The VF-14 is a valid measure of functional visual impairment in candidates for a corneal graft. The Visual Symptom Score and the SF-36 are also useful indices in such patients.
验证用于角膜移植候选者功能性视力损害的视力功能-14(VF-14)指标。
1996年8月至1997年2月期间,134名角膜移植候选者参与了本研究。收集了人口统计学、眼部病史、最佳矫正视力和详细的眼部检查数据。通过电话访谈获得功能性视力损害信息,使用以下方法:VF-14、SF-36(简短健康调查问卷-36,一种更通用的总体健康功能测量方法)、视觉症状评分,以及四个测量视力问题总体严重程度、视力不满意程度、眼痛和不适的问题。
角膜移植候选者的平均年龄为64±18岁(范围为18至90岁),60%为女性。最常见的角膜疾病是人工晶状体性大泡性角膜病变(41%)。眼部合并症包括青光眼或高眼压(30%)和白内障(19%)。计划手术眼的平均最佳矫正视力为1.33±0.56 logMAR,而最佳眼的最佳矫正视力为0.36±0.44 logMAR。VF-14的平均得分为73%±26%,内部一致性较高,Cronbach α值为0.94。VF-14与最佳眼的最佳矫正视力密切相关。它还与视觉症状评分、视力问题和视力不满意程度的总体测量密切相关。角膜移植候选者在使用SF-36评估的所有八个总体健康概念上得分较低,并且VF-14与八个SF-36子量表中的七个相关。
VF-14是角膜移植候选者功能性视力损害的有效测量指标。视觉症状评分和SF-36在此类患者中也是有用的指标。